Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.46)
# 904
Out of 4,944 analysts
144
Total ratings
51.8%
Success rate
2.38%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHE Chemed | Maintains: Outperform | $650 → $580 | $449.68 | +28.98% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $270.18 | +20.29% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $27.08 | +58.79% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $279.17 | +11.04% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $286.00 | +31.12% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.29 | +64.61% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $26.80 | +38.06% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $390.99 | +2.30% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $165.23 | +1.68% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $115.06 | +26.02% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $11.51 | +247.52% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $2.68 | +86.57% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $7.72 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $100.97 | +43.61% | 10 | Oct 28, 2022 |
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $449.68
Upside: +28.98%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $270.18
Upside: +20.29%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $27.08
Upside: +58.79%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $279.17
Upside: +11.04%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $286.00
Upside: +31.12%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.29
Upside: +64.61%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $26.80
Upside: +38.06%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $390.99
Upside: +2.30%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $165.23
Upside: +1.68%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $115.06
Upside: +26.02%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $11.51
Upside: +247.52%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $2.68
Upside: +86.57%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $7.72
Upside: -
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $100.97
Upside: +43.61%